Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid

Nucleic Acids Research

Volumn 41, Issue 6, 2013, Pages 3874-3887

  Nowak, Elzbieta ^a   Potrzebowski, Wojciech ^a   Konarev, Petr V ^b   Rausch, Jason W ^c   Bona, Marion K ^c   Svergun, Dmitri I ^b   Bujnicki, Janusz M ^a,d   Le Grice, Stuart F J ^c   Nowotny, Marcin ^a  

^a INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c Nanobiology Program   (United States)

^d ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; PROTEIN P51; PROTEIN P66; RIBONUCLEASE H; RNA; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CRYSTAL STRUCTURE; DNA RNA HYBRIDIZATION; ENZYME ACTIVE SITE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION; SITE DIRECTED MUTAGENESIS; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION; XENOTROPIC MULV RELATED VIRUS;

AMINO ACID SEQUENCE; DNA; HIV REVERSE TRANSCRIPTASE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RNA; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 84876054958     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt053     Document Type: Article

References (81)

1. Gilboa, E., Mitra, S.W., Goff,S. and Baltimore, D. (1979) A detailed model of reverse transcription and tests of crucial aspects. Cell, 18, 93-100.
2. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. and Steitz, T.A. (1992) Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science, 256, 1783-1790.
3. Herschhorn,A. and Hizi, A. (2010) Retroviral reverse transcriptases. Cell. Mol. Life Sci., 67, 2717-2747.
4. North, T.W., Cronn, R.C., Remington, K.M., Tandberg, R.T. and Judd, R.C. (1990) Characterization of reverse transcriptase from feline immunodeficiency virus. J. Biol. Chem., 265, 5121-5128.
5. Thomas, D.A. and Furman, P.A. (1991) Purification and kinetic characterization of equine infectious anemia virus reverse transcriptase. Biochem. Biophys. Res. Commun., 180, 1365-1371.
6. Cote, M.L. and Roth, M.J. (2008) Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase. Virus Res., 134, 186-202.
7. Moelling, K. (1974) Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus. Virology, 62, 46-59.
8. Roth, M.J., Tanese,N. and Goff, S.P. (1985) Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J. Biol. Chem., 260, 9326-9335.
9. Das,D. and Georgiadis, M.M. (2004) The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure, 12, 819-829.
10. Ding, J., Das, K., Hsiou, Y., Sarafianos, S.G., Clark, A.D. Jr, Jacobo-Molina, A., Tantillo, C., Hughes, S.H. and Arnold, E. (1998) Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. J. Mol. Biol., 284, 1095-1111.
11. Huang, H., Chopra, R., Verdine, G.L. and Harrison, S.C. (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science, 282, 1669-1675.
12. Sarafianos, S.G., Das, K., Tantillo, C., Clark, A.D. Jr, Ding, J., Whitcomb, J.M., Boyer, P.L., Hughes, S.H. and Arnold, E. (2001) Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J., 20, 1449-1461.
13. Cote, M.L., Yohannan, S.J. and Georgiadis, M.M. (2000) Use of an N-terminal fragment from moloney murine leukemia virus reverse transcriptase to facilitate crystallization and analysis of a pseudo-16-mer DNA molecule containing G-A mispairs. Acta. Crystallogr. D Biol. Crystallogr., 56, 1120-1131.
14. Najmudin, S., Cote, M.L., Sun, D., Yohannan, S., Montano, S.P., Gu,J. and Georgiadis, M.M. (2000) Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain. J. Mol. Biol., 296, 613-632.
15. Sun, D., Jessen, S., Liu, C., Liu, X., Najmudin,S. and Georgiadis, M.M. (1998) Cloning, expression, and purification of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase: crystallization of nucleic acid complexes. Protein Sci., 7, 1575-1582.
16. Tisdale, M., Schulze, T., Larder, B.A. and Moelling, K. (1991) Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J. Gen. Virol., 72(Pt 1), 59-66.
17. Schultz, S.J. and Champoux, J.J. (1996) RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity. J. Virol., 70, 8630-8638.
18. Zhan,X. and Crouch, R.J. (1997) The isolated RNase H domain of murine leukemia virus reverse transcriptase. Retention of activity with concomitant loss of specificity. J. Biol. Chem., 272, 22023-22029.
19. Nowotny, M., Gaidamakov, S.A., Ghirlando, R., Cerritelli, S.M., Crouch, R.J. and Yang, W. (2007) Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription. Mol. Cell, 28, 264-276.
20. Telesnitsky,A. and Goff, S.P. (1993) RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template. Proc. Natl Acad. Sci. USA, 90, 1276-1280.
21. Kirby, K.A., Marchand, B., Ong, Y.T., Ndongwe, T.P., Hachiya, A., Michailidis, E., Leslie, M.D., Sietsema, D.V., Fetterly, T.L., Dorst, C.A. et al. (2012) Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase. Antimicrob. Agents Chemother., 56, 2048-2061.
22. Lim, D., Gregorio, G.G., Bingman, C., Martinez-Hackert, E., Hendrickson, W.A. and Goff, S.P. (2006) Crystal structure of the moloney murine leukemia virus RNase H domain. J. Virol., 80, 8379-8389.
23. Zhou, D., Chung, S., Miller, M., Le Grice, S.F. and Wlodawer, A. (2012) Crystal structures of the reverse transcriptase-associated ribonuclease H domain of Xenotropic murine leukemia-virus related virus. J. Struct. Biol., 177, 638-645.
24. Schlaberg, R., Choe, D.J., Brown, K.R., Thaker, H.M. and Singh, I.R. (2009) XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc. Natl Acad. Sci. USA, 106, 16351-16356.
25. Lombardi, V.C., Ruscetti, F.W., Das Gupta, J., Pfost, M.A., Hagen, K.S., Peterson, D.L., Ruscetti, S.K., Bagni, R.K., Petrow-Sadowski, C., Gold, B. et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science, 326, 585-589.
26. Mikovits, J.A., Lombardi, V.C., Pfost, M.A., Hagen,S. and Ruscetti, F.W. (2010) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence, 1, 386-390.
27. Delviks-Frankenberry, K., Cingoz, O., Coffin, J.M. and Pathak, V.K. (2012) Recombinant origin, contamination, and de-discovery of XMRV. Curr. Opin. Virol., 2, 499-507.
28. Paprotka, T., Delviks-Frankenberry, K.A., Cingoz, O., Martinez, A., Kung, H.J., Tepper, C.G., Hu, W.S., Fivash, M.J. Jr, Coffin, J.M. and Pathak, V.K. (2011) Recombinant origin of the retrovirus XMRV. Science, 333, 97-101.
29. Wohrl, B.M., Georgiadis, M.M., Telesnitsky, A., Hendrickson, W.A. and Le Grice, S.F. (1995) Footprint analysis of replicating murine leukemia virus reverse transcriptase. Science, 267, 96-99.
30. Mueller, U., Darowski, N., Fuchs, M.R., Forster, R., Hellmig, M., Paithankar, K.S., Puhringer, S., Steffien, M., Zocher,G. and Weiss, M.S. (2012) Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin. J. Synchrotron Radiat., 19, 442-449.
31. Otwinowski,Z. and Minor, W. (1997) In: Carter, C.W. and Sweet, R.M. (eds), Methods in Enzymol, Vol. 276. Academic Press, New York, pp. 307-326.
32. McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C. and Read, R.J. (2007) Phaser crystallographic software. J. Appl. Crystallogr., 40, 658-674.
33. Emsley, P., Lohkamp, B., Scott, W.G. and Cowtan, K. (2010) Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr., 66, 486-501.
34. Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W. et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr., 66, 213-221.
35. Brunger, A.T. (2007) Version 1.2 of the Crystallography and NMR system. Nat. Protoc., 2, 2728-2733.
36. Lavery, R., Moakher, M., Maddocks, J.H., Petkeviciute,D. and Zakrzewska, K. (2009) Conformational analysis of nucleic acids revisited: Curves+. Nucleic Acids Res., 37, 5917-5929.
37. Chung, S., Miller, J.T., Johnson, B.C., Hughes, S.H. and Le Grice, S.F. (2012) Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity. J. Biol. Chem., 287, 4066-4075.
38. Blanchet, C.E., Zozulya, A.V., Kikhney, A.G., Franke, D., Konarev, P.V., Shang, W., Klaering, R., Robrahn, B., Hermes, C., Cipriani, F. et al. (2012) Instrumental setup for high-throughput small-and wide-angle solution scattering at the X33 beamline of EMBL Hamburg. J. Appl. Cryst., 45, 489-495.
39. Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M.H.J. and Svergun, D.I. (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Cryst., 36, 1277-1282.
40. Svergun, D.I. (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Cryst., 25, 495-503.
41. Franke,D. and Svergun, D.I. (2009) DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. J. Appl. Cryst., 42, 342-346.
42. Volkov, V.V. and Svergun, D.I. (2003) Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Cryst., 36, 860-864.
43. Svergun, D.I. (1999) Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J., 76, 2879-2886.
44. Kozin, M.B. and Svergun, D.I. (2001) Automated matching of highand low-resolution structural models. J. Appl. Cryst., 34, 33-41.
45. Bernado, P., Mylonas, E., Petoukhov, M.V., Blackledge,M. and Svergun, D.I. (2007) Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. Chem. Soc., 129, 5656-5664.
46. Boniecki, M., Rotkiewicz, P., Skolnick,J. and Kolinski, A. (2003) Protein fragment reconstruction using various modeling techniques. J. Comput. Aided Mol. Des., 17, 725-738.
47. Svergun, D., Barberato,C. and Koch, M.H.J. (1995) CRYSOL -a Program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Cryst., 28, 768-773.
48. Georgiadis, M.M., Jessen, S.M., Ogata, C.M., Telesnitsky, A., Goff, S.P. and Hendrickson, W.A. (1995) Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure, 3, 879-892.
49. Paulson, B.A., Zhang, M., Schultz, S.J. and Champoux, J.J. (2007) Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo. Virology, 366, 361-376.
50. Winshell,J. and Champoux, J.J. (2001) Structural alterations in the DNA ahead of the primer terminus during displacement synthesis by reverse transcriptases. J. Mol. Biol., 306, 931-943.
51. Agopian, A., Depollier, J., Lionne,C. and Divita, G. (2007) p66 Trp24 and Phe61 are essential for accurate association of HIV-1 reverse transcriptase with primer/template. J. Mol. Biol., 373, 127-140.
52. Gu, J., Villanueva, R.A., Snyder, C.S., Roth, M.J. and Georgiadis, M.M. (2001) Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity. J. Mol. Biol., 305, 341-359.
53. Pfeiffer, J.K., Georgiadis, M.M. and Telesnitsky, A. (2000) Structure-based moloney murine leukemia virus reverse transcriptase mutants with altered intracellular direct-repeat deletion frequencies. J. Virol., 74, 9629-9636.
54. Boyer, P.L., Ferris, A.L. and Hughes, S.H. (1992) Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol., 66, 1031-1039.
55. Kim, B., Ayran, J.C., Sagar, S.G., Adman, E.T., Fuller, S.M., Tran, N.H. and Horrigan, J. (1999) New human immunodeficiency virus, type 1 reverse transcriptase (HIV-1 RT) mutants with increased fidelity of DNA synthesis. Accuracy, template binding, and processivity. J. Biol. Chem., 274, 27666-27673.
56. Bohlayer, W.P. and DeStefano, J.J. (2006) Tighter binding of HIV reverse transcriptase to RNA-DNA versus DNA-DNA results mostly from interactions in the polymerase domain and requires just a small stretch of RNA-DNA. Biochemistry, 45, 7628-7638.
57. Gao, H.Q., Boyer, P.L., Arnold,E. and Hughes, S.H. (1998) Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase. J. Mol. Biol., 277, 559-572.
58. Rattray, A.J. and Champoux, J.J. (1989) Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H. J. Mol. Biol., 208, 445-456.
59. Kurowski, M.A. and Bujnicki, J.M. (2003) GeneSilico protein structure prediction meta-server. Nucleic Acids Res., 31, 3305-3307.
60. Schultz, S.J., Zhang,M. and Champoux, J.J. (2009) Preferred sequences within a defined cleavage window specify DNA 30 end-directed cleavages by retroviral RNases H. J. Biol. Chem., 284, 32225-32238.
61. Pullen, K.A. and Champoux, J.J. (1990) Plus-strand origin for human immunodeficiency virus type 1: implications for integration. J. Virol., 64, 6274-6277.
62. Pullen, K.A., Rattray, A.J. and Champoux, J.J. (1993) The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J. Biol. Chem., 268, 6221-6227.
63. Wu, N., Christendat, D., Dharamsi,A. and Pai, E.F. (2000) Purification, crystallization and preliminary X-ray study of orotidine 5′-monophosphate decarboxylase. Acta Crystallogr. D Biol. Crystallogr., 56, 912-914.
64. Evans, P. (2006) Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr., 62, 72-82.
65. Karplus, P.A. and Diederichs, K. (2012) Linking crystallographic model and data quality. Science, 336, 1030-1033.
66. Goodwin, K.D., Long, E.C. and Georgiadis, M.M. (2005) A host-guest approach for determining drug-DNA interactions: an example using netropsin. Nucleic Acids Res., 33, 4106-4116.
67. Chowdhury, K., Kaushik, N., Pandey, V.N. and Modak, M.J. (1996) Elucidation of the role of Arg 110 of murine leukemia virus reverse transcriptase in the catalytic mechanism: biochemical characterization of its mutant enzymes. Biochemistry, 35, 16610-16620.
68. Basu, A., Basu,S. and Modak, M.J. (1990) Site-directed mutagenesis of Moloney murine leukemia virus reverse transcriptase. Demonstration of lysine 103 in the nucleotide binding site. J. Biol. Chem., 265, 17V162-17166.
69. Gao, G., Orlova, M., Georgiadis, M.M., Hendrickson, W.A. and Goff, S.P. (1997) Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. Proc. Natl Acad. Sci. USA, 94, 407-411.
70. Drosopoulos, W.C. and Prasad, V.R. (1996) Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase. J. Virol., 70, 4834-4838.
71. Oude Essink, B.B., Back, N.K. and Berkhout, B. (1997) Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucleic Acids Res., 25, 3212-3217.
72. Pandey, V.N., Kaushik, N., Rege, N., Sarafianos, S.G., Yadav, P.N. and Modak, M.J. (1996) Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis. Biochemistry, 35, 2168-2179.
73. Wainberg, M.A., Drosopoulos, W.C., Salomon, H., Hsu, M., Borkow, G., Parniak, M., Gu, Z., Song, Q., Manne, J., Islam, S. et al. (1996) Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science, 271, 1282-1285.
74. Roberts, J.D., Bebenek,K. and Kunkel, T.A. (1988) The accuracy of reverse transcriptase from HIV-1. Science, 242, 1171-1173.
75. Eswar, N., Webb, B., Marti-Renom, M.A., Madhusudhan, M.S., Eramian, D., Shen, M.Y., Pieper,U. and Sali, A. (2006) Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinformatics, (Chapter 5), Unit 5.6.
76. Sgourakis, N.G., Lange, O.F., DiMaio, F., Andre, I., Fitzkee, N.C., Rossi, P., Montelione, G.T., Bax,A. and Baker, D. (2011) Determination of the structures of symmetric protein oligomers from NMR chemical shifts and residual dipolar couplings. J. Am. Chem. Soc., 133, 6288-6298.
77. Gorba, C., Miyashita,O. and Tama, F. (2008) Normal-mode flexible fitting of high-resolution structure of biological molecules toward one-dimensional low-resolution data. Biophys. J., 94, 1589-1599.
78. Xiong,Y. and Eickbush, T.H. (1988) Similarity of reverse transcriptase-like sequences of viruses, transposable elements, and mitochondrial introns. Mol. Biol. Evol., 5, 675-690.
79. Puglia, J., Wang, T., Smith-Snyder, C., Cote, M., Scher, M., Pelletier, J.N., John, S., Jonsson, C.B. and Roth, M.J. (2006) Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins. J. Virol., 80, 9497-9510.
80. Tanese, N., Telesnitsky,A. and Goff, S.P. (1991) Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function. J. Virol., 65, 4387-4397.
81. Leo, B., Schweimer, K., Rosch, P., Hartl, M.J. and Wohrl, B.M. (2012) The solution structure of the prototype foamy virus RNase H domain indicates an important role of the basic loop in substrate binding. Retrovirology, 9, 73.